Dexcom stock kpis
Want to see DXCM full AI Analyst Report?
Revenue by Segment
Dexcom reported revenue by segment of $1.21B in Q3 2025, up 4.5% from Q2 2025 and up 21.6% year over year. This is the highest value since 2020.
Shows how revenue is distributed across different business segments, highlighting which areas are driving growth and which may need strategic attention.
DexCom's Sensor and Other segment shows strong growth momentum, with recent quarters reflecting significant revenue increases. This aligns with the earnings call, which highlights robust revenue growth and strategic expansions, particularly in type 2 diabetes CGM coverage. However, the Hardware segment is experiencing a decline, possibly due to quality and deployment issues with the G7 sensor. Despite these challenges, DexCom's strategic innovations like the Smart Basal and successful product launches such as Stelo are driving positive sentiment and long-term growth prospects.
No longer reported by the company (last reported Q3 2025)
DXCM Revenue by Segment
| Period | Sensor and Other | Hardware | Total |
|---|---|---|---|
| Q3 2025Sep 30, 2025 | $1.18B | $34.20M | $1.21B |
| Q2 2025Jun 30, 2025 | $1.12B | $39.30M | $1.16B |
| Q1 2025Mar 31, 2025 | $997.20M | $38.80M | $1.04B |
| Q4 2024Dec 31, 2024 | $1.07B | $45.00M | $1.11B |
| Q3 2024Sep 30, 2024 | $951.80M | $42.40M | $994.20M |
| Q2 2024Jun 30, 2024 | $947.00M | $57.30M | $1.00B |
| Q1 2024Mar 31, 2024 | $854.30M | $66.70M | $921.00M |
| Q4 2023Dec 31, 2023 | $947.00M | $87.50M | $1.03B |
| Q3 2023Sep 30, 2023 | $873.80M | $101.20M | $975.00M |
| Q2 2023Jun 30, 2023 | $778.00M | $93.30M | $871.30M |
| Q1 2023Mar 31, 2023 | $651.90M | $89.60M | $741.50M |
| Q4 2022Dec 31, 2022 | $714.80M | $100.40M | $815.20M |
| Q3 2022Sep 30, 2022 | $666.60M | $103.00M | $769.60M |
| Q2 2022Jun 30, 2022 | $597.70M | $98.50M | $696.20M |
| Q1 2022Mar 31, 2022 | $543.20M | $85.60M | $628.80M |
| Q4 2021Dec 31, 2021 | $598.60M | $99.60M | $698.20M |
| Q3 2021Sep 30, 2021 | $547.90M | $102.30M | $650.20M |
| Q2 2021Jun 30, 2021 | $494.50M | $100.60M | $595.10M |
| Q1 2021Mar 31, 2021 | $424.30M | $80.70M | $505.00M |
| Q4 2020Dec 31, 2020 | $465.60M | $103.30M | $568.90M |
| Q3 2020Sep 30, 2020 | $406.30M | $94.60M | $500.90M |
| Q2 2020Jun 30, 2020 | $364.50M | $87.30M | $451.80M |
| Q1 2020Mar 31, 2020 | $325.00M | $80.10M | $405.10M |

